• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-放射性标记及一种 AMD3465 衍生物用于 CXCR4 在小鼠乳腺癌模型中 PET 成像的评价。

F-Radiolabeling and Evaluation of an AMD3465 Derivative for PET Imaging of CXCR4 in a Mouse Breast Tumor Model.

机构信息

Henan Joint International Research Laboratory of Living Polymerizations and Functional Nanomaterials, Henan Key Laboratory of Advanced Nylon Materials and Application, School of Materials Science and Engineering, Zhengzhou University, Zhengzhou 450001, China.

Department of Nuclear Medicine, Henan Key Laboratory of Novel Molecular Probes and Clinical Translation in Nuclear Medicine, Henan Provincial People's Hospital & the People's Hospital of Zhengzhou University, Zhengzhou 450003, China.

出版信息

Bioconjug Chem. 2024 May 15;35(5):567-574. doi: 10.1021/acs.bioconjchem.4c00167. Epub 2024 Apr 18.

DOI:10.1021/acs.bioconjchem.4c00167
PMID:38634516
Abstract

The exploration of pharmaceutically active agents and positron emission tomography (PET) tracers targeting CXCR4 has been a focal point in cancer research given its pivotal role in the development and progression of various cancers. While significant strides have been made in PET imaging with radiometal-labeled tracers, the landscape of F-labeled small molecule tracers remains relatively limited. Herein, we introduce a novel and promising derivative, [F]SFB-AMD3465, as a targeted PET tracer for CXCR4. The compound was synthesized by modifying the pyridine ring of AMD3465, which was subsequently labeled with F using [F]SFB. The study provides comprehensive insights into the design, synthesis, and biological evaluation of [F]SFB-AMD3465. and assessments demonstrated the CXCR4-dependent, specific, and sensitive uptake of [F]SFB-AMD3465 in the CXCR4-overexpressing 4T1 cell line and the corresponding xenograft-bearing mouse model. These findings contribute to bridging the gap in F-labeled PET tracers for CXCR4 and underscore the potential of [F]SFB-AMD3465 as a PET radiotracer for CXCR4 imaging.

摘要

探索针对 CXCR4 的药物活性化合物和正电子发射断层扫描 (PET) 示踪剂一直是癌症研究的重点,因为它在各种癌症的发展和进展中起着关键作用。虽然使用放射性金属标记示踪剂在 PET 成像方面取得了重大进展,但 F 标记小分子示踪剂的领域仍然相对有限。在此,我们介绍了一种新型且有前途的衍生物 [F]SFB-AMD3465,作为 CXCR4 的靶向 PET 示踪剂。该化合物通过修饰 AMD3465 的吡啶环合成,随后使用 [F]SFB 对其进行 F 标记。该研究提供了对 [F]SFB-AMD3465 的设计、合成和生物学评估的全面了解。评估表明,[F]SFB-AMD3465 在 CXCR4 过表达的 4T1 细胞系和相应的荷瘤小鼠模型中表现出 CXCR4 依赖性、特异性和敏感性摄取。这些发现有助于缩小 F 标记的 CXCR4 PET 示踪剂之间的差距,并强调了 [F]SFB-AMD3465 作为 CXCR4 成像的 PET 放射性示踪剂的潜力。

相似文献

1
F-Radiolabeling and Evaluation of an AMD3465 Derivative for PET Imaging of CXCR4 in a Mouse Breast Tumor Model.F-放射性标记及一种 AMD3465 衍生物用于 CXCR4 在小鼠乳腺癌模型中 PET 成像的评价。
Bioconjug Chem. 2024 May 15;35(5):567-574. doi: 10.1021/acs.bioconjchem.4c00167. Epub 2024 Apr 18.
2
Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.评估N-[(11)C]甲基-AMD3465作为正电子发射断层扫描(PET)示踪剂在C6胶质瘤肿瘤模型中对CXCR4受体表达进行成像的效果。
Mol Pharm. 2014 Nov 3;11(11):3810-7. doi: 10.1021/mp500398r. Epub 2014 Aug 18.
3
[F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.[F]RPS-544:一种用于成像趋化因子受体 CXCR4 的 PET 示踪剂。
Nucl Med Biol. 2018 May;60:37-44. doi: 10.1016/j.nucmedbio.2018.01.004. Epub 2018 Jan 31.
4
PET imaging of CXCR4 expression using [F]AlF-NOTA-QHY-04 for hematologic malignancy and solid tumors.使用 [F]AlF-NOTA-QHY-04 进行 CXCR4 表达的 PET 成像,用于血液恶性肿瘤和实体肿瘤。
Theranostics. 2024 Sep 30;14(16):6337-6349. doi: 10.7150/thno.99025. eCollection 2024.
5
Development and Evaluation of an F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression.开发和评价一种 F-放射性标记的单环酰胺衍生物用于 CXCR4 表达成像。
Mol Pharm. 2019 May 6;16(5):2106-2117. doi: 10.1021/acs.molpharmaceut.9b00069. Epub 2019 Apr 3.
6
N-[C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs.N-[C]甲基-AMD3465正电子发射断层扫描(PET)作为一种体内测量治疗药物对趋化因子受体4(CXCR4)占有率的工具
Mol Imaging Biol. 2017 Aug;19(4):570-577. doi: 10.1007/s11307-016-1028-8.
7
Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[C]Methyl-AMD3465 PET.N-[C]甲基-AMD3465 PET 可无创监测肿瘤异种移植中 CXCR4 表达的治疗诱导变化。
Mol Imaging Biol. 2020 Aug;22(4):883-890. doi: 10.1007/s11307-019-01447-x.
8
Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.在人源肿瘤异种移植模型中评估 CXCR4 表达的影像学研究:单环酰胺 64Cu-AMD3465 的评价。
J Nucl Med. 2011 Jun;52(6):986-93. doi: 10.2967/jnumed.110.085613.
9
Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.比较(18)F 标记的 CXCR4 拮抗剂肽用于 CXCR4 表达的 PET 成像。
Mol Imaging Biol. 2013 Dec;15(6):758-67. doi: 10.1007/s11307-013-0640-0.
10
High-Contrast CXCR4-Targeted F-PET Imaging Using a Potent and Selective Antagonist.高对比度 CXCR4 靶向 F-PET 成像使用有效且选择性的拮抗剂。
Mol Pharm. 2021 Jan 4;18(1):187-197. doi: 10.1021/acs.molpharmaceut.0c00785. Epub 2020 Nov 30.

引用本文的文献

1
New Radiopharmaceutical Tracers in Breast Cancer Diagnosis and Therapy.用于乳腺癌诊断与治疗的新型放射性药物示踪剂
Anticancer Agents Med Chem. 2025;25(16):1198-1217. doi: 10.2174/0118715206357095250306051714.
2
Molecular Imaging of Cancer Stem Cells and Their Role in Therapy Resistance.癌症干细胞的分子成像及其在治疗抗性中的作用。
J Nucl Med. 2025 Jan 3;66(1):14-19. doi: 10.2967/jnumed.124.267657.